CN Patent

CN103127024B — 稳定的三磷酸腺苷二钠片剂

Assigned to CHENGDU TIANTAISHAN PHARMACEUTICAL CO LTD · Expires 2014-10-15 · 12y expired

What this patent protects

本发明涉及一种稳定的三磷酸腺苷二钠片剂。具体而言，本发明涉及一种稳定的含有三磷酸腺苷或其药用盐的固体药物组合物。更具体地涉及即使长期保存后有效成分含量也可高度维持的保存稳定性优异的含有三磷酸腺苷或其药用盐的固体药物组合物。本发明固体药物组合物中包含作为活性成分的三磷酸腺苷或其药用盐、钙盐以及任选的药用辅料。

USPTO Abstract

本发明涉及一种稳定的三磷酸腺苷二钠片剂。具体而言，本发明涉及一种稳定的含有三磷酸腺苷或其药用盐的固体药物组合物。更具体地涉及即使长期保存后有效成分含量也可高度维持的保存稳定性优异的含有三磷酸腺苷或其药用盐的固体药物组合物。本发明固体药物组合物中包含作为活性成分的三磷酸腺苷或其药用盐、钙盐以及任选的药用辅料。

Drugs covered by this patent

ribociclib-succinate (RIBOCICLIB SUCCINATE)

Patent Metadata

Patent number: CN103127024B
Jurisdiction: CN
Classification: —
Expires: 2014-10-15
Drug substance claim: No
Drug product claim: No
Assignee: CHENGDU TIANTAISHAN PHARMACEUTICAL CO LTD
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.